Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Lexicon presents early clinical results of LX-6171 at the AAN meeting

April 18, 2008

Treximet receives FDA approval for acute treatment of migraine

April 17, 2008

Paratek's novel tetracycline derivative shows potential for treating spinal muscular atrophy

April 17, 2008

PAION to acquire CeNeS and discontinue development of neuroprotectant enecadin

April 17, 2008

Silenor insomnia NDA accepted for filing

April 16, 2008

H3 antagonists developed at Wyeth for cognitive dysfunction

April 16, 2008

Jazz Pharmaceuticals' Luvox now available in the U.S. for treatment of SAD and OCD

April 16, 2008

Johnson & Johnson submits supplemental NDA for Risperdal Consta in FRBD

April 16, 2008

European Commission approves Effentora for breakthrough cancer pain

April 16, 2008

Rituxan fails to meet primary endpoint in primary-progressive MS study

April 15, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...